HIV 1 News and Research

RSS

Lawsuit against California Department of Health Care Services

AIDS Healthcare Foundation (AHF) has filed a federal lawsuit against David Maxwell-Jolly, Director of the California Department of Health Care Services (DHCS) seeking an injunction to prevent implementation of a new state law singling out nonprofit safety net providers—including AHF—forcing drastic Medi-Cal (Medicaid) reimbursements cuts for drugs purchased by AHF clinics and other safety net providers while favoring giant national for-profit pharmacy chains including Rite Aid, CVS, Walgreens and others.

10 Nov 2009

Study on how robust antibodies work to block the HIV virus raise hope for new vaccine

A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine.

10 Nov 2009

Speaker Pelosi praises H.R. 3962 that will improve Medicaid access to HIV/AIDS-affected people

"Effective drug treatments have improved both health and quality of life for thousands of Americans living with HIV/AIDS. However, many uninsured, low-income HIV-positive individuals still do not have access to these life-saving medications because they generally do not meet Medicaid requirements until becoming disabled by full-blown AIDS.

10 Nov 2009

Kenya to launch MSM survey to help control spread of HIV

TIME examines the Kenyan government's upcoming survey of gay men and other men who have sex with men (MSM) in the country's "three biggest cities" in an effort to fight the spread of HIV/AIDS.

10 Nov 2009

Needle exchanges could be limited under Congressional bill

The New York Times reports on federal legislation that could limit needle exchanges. "A bill working its way through Congress would lift a ban of more than 20 years on using federal money for needle exchange programs.

10 Nov 2009

Concert Pharmaceuticals commences Phase 1b clinical study of its CTP-518 HIV protease inhibitor

Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase 1b clinical study with CTP-518, its investigational oral HIV protease inhibitor for the treatment of HIV infection. In connection with the start of this multiple ascending dose arm of the Phase 1 study, Concert will receive a $12 million milestone payment under the company’s strategic alliance with GlaxoSmithKline.

9 Nov 2009

Lubricants improve the comfort and pleasure of sexual intercourse, and reduce the risk of injury

An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex.

9 Nov 2009

Transatlantic task force to address antibiotic resistance established, experts welcome initiative

Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.

7 Nov 2009

Experts applaud the EU Presidency for establishing a transatlantic task force to address antibiotic resistance

7 Nov 2009

San Francisco map of HIV viral loads shows where care lags

Researchers in San Francisco have identified how much virus people infected with HIV are carrying and mapped their results, which show that that AIDS treatment lags in certain neighborhoods. The work also showed that the sickest patients were often African-American, homeless and transgender.

7 Nov 2009

NIH awards UAB School of Public Health $11.5M to research new methods of identifying youth with HIV

The University of Alabama at Birmingham (UAB) School of Public Health has been awarded a total of $11.5 million from the National Institutes of Health to explore new ways to identify adolescents and young adults infected with human immunodeficiency virus (HIV) and link them to medical care.

7 Nov 2009

Men's Wellness Center launched at AHF Blair Underwood Healthcare Center’

On Thursday, November 5th, AIDS Healthcare Foundation (AHF), the largest global AIDS organization, which provides medical care and/or services to more than 120,000 individuals in 22 countries worldwide, opened a Men's Wellness Center at the new ‘AHF Blair Underwood Healthcare Center’ located in Washington D.C.

7 Nov 2009

GeoVax Labs announces financial results and operational update for the third quarter of 2009

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.

6 Nov 2009

Publications examine U.S. funding for global HIV/AIDS

In light of a Medecins Sans Frontieres (MSF) report calling for sustained HIV/AIDS funding, VOA News writes: "Many AIDS-related groups and activists have been calling on U.S. President Barack Obama to fulfill his funding pledges made during the presidential campaign. But are they asking too much, considering the economic downturn?" Sharonann Lynch, an HIV policy advisor for MSF, said, "PEPFAR has the opportunity to save six million lives and it shouldn't settle for three."

6 Nov 2009

President Obama discusses Africa's HIV/AIDS epidemic with president of Botswana

President Barack Obama met with Botswana's president, Ian Khama, on Thursday to discuss issues facing the country, including the spread of HIV/AIDS in Africa, Bloomberg reports (Johnston, 11/5).

6 Nov 2009

Gonorrhea medication may help fight cancer

Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns Hopkins University School of Medicine is a gonorrhea medication that might help battle cancer.

6 Nov 2009

National Institutes of Health grants $6-million for brain disease research

Brown University, in collaboration with two other institutions, has been awarded a five-year, $6-million National Institutes of Health program project grant to help determine how a virus that can cause a rare brain disease attaches to host cells.

6 Nov 2009

ART as part of HIV prevention strategy supported by WHO

"AIDS drugs should be given to all who need them to reduce new infections, the World Health Organization said," following a three-day meeting on the topic of using antiretroviral therapy (ART) to help prevent the spread of HIV, Bloomberg reports. "Providing more antiretroviral drugs 'will achieve a significant transmission benefit,' Teguest Guerma, interim director of the WHO's AIDS department, said … 'In the past, there has been a false dichotomy between prevention and treatment. …'That is really what has been corrected. Prevention and treatment are two faces of the same coin'" (Bennett, 11/5).

6 Nov 2009

Future for magnetic nanoparticles appears even brighter

Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping of our hearts), mNPs have come a long way in the past decade.

6 Nov 2009

New findings may lead to novel therapeutic approaches for HIV and prostate cancer

New Haven, Conn.-Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.

6 Nov 2009

HIV 1 News and Research

Lawsuit against California Department of Health Care Services

Study on how robust antibodies work to block the HIV virus raise hope for new vaccine

Speaker Pelosi praises H.R. 3962 that will improve Medicaid access to HIV/AIDS-affected people

Kenya to launch MSM survey to help control spread of HIV

Needle exchanges could be limited under Congressional bill

Concert Pharmaceuticals commences Phase 1b clinical study of its CTP-518 HIV protease inhibitor

Lubricants improve the comfort and pleasure of sexual intercourse, and reduce the risk of injury

Transatlantic task force to address antibiotic resistance established, experts welcome initiative

Experts applaud the EU Presidency for establishing a transatlantic task force to address antibiotic resistance

San Francisco map of HIV viral loads shows where care lags

NIH awards UAB School of Public Health $11.5M to research new methods of identifying youth with HIV

Men's Wellness Center launched at AHF Blair Underwood Healthcare Center’

GeoVax Labs announces financial results and operational update for the third quarter of 2009

Publications examine U.S. funding for global HIV/AIDS

President Obama discusses Africa's HIV/AIDS epidemic with president of Botswana

Gonorrhea medication may help fight cancer

National Institutes of Health grants $6-million for brain disease research

ART as part of HIV prevention strategy supported by WHO

Future for magnetic nanoparticles appears even brighter

New findings may lead to novel therapeutic approaches for HIV and prostate cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News